Floatz logo

Minnelide

Solid Carcinoma of Stomach

Minneamrita Therapeutics LLCPhase 1Dormant
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
95/ 100

Competitive context

65 Active assets in the Solid Carcinoma of Stomach cohort.

Asset / SponsorPhaseRating
FLUOROURACILUM
Boehringer Ingelheim
Phase 3BB
Eloxatin
Shanghai Zhongshan Hospital
Phase 3BB
Capecitabine
Shanghai Zhongshan Hospital
Phase 3BB
CIS-DIAMMINEDICHLOROPLATINUM II
Mayo Clinic
Phase 3BB
TRASTUZUMAB
Boehringer Ingelheim
Phase 2BB

View all 50 →

Same molecule, other indications

Minnelide is also rated in:

pancreatic adenosquamous carcinomaDormant
B
Indicative ·
57 / 100
View asset →
pancreatic neoplasmDormant
CCC
Indicative ·
53 / 100
View asset →
Cancer of StomachDormant
CC
Indicative ·
43 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →